Cartalax (AED; Ala-Glu-Asp) is an investigational short-peptide research material studied in laboratory models involving cartilage-cell differentiation, extracellular-matrix markers, and short-peptide regulation of gene expression. The available evidence is predominantly preclinical. For laboratory research use only.
These are order-level reviews from the same warehouse, not ratings of this individual product.
Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp (AED). Laboratory studies have examined AED in cell models involving chondrogenic differentiation and the expression of cartilage-associated markers such as SOX9, aggrecan, type II collagen, and COMP.
Reviews of short-peptide research also discuss peptide-DNA interaction and gene-expression regulation as proposed mechanisms for AED-class peptides. These observations are model-dependent, and no single validated receptor or established clinical mechanism has been confirmed for Cartalax.
Cartalax is supplied as a lyophilized powder. Unopened vials can be stored for up to 2 years at 2-8°C when kept sealed, dry, and protected from light. Avoid excessive heat, moisture, and repeated temperature changes.
After reconstitution with bacteriostatic water, store at 2-8°C, protected from light, and use within 30 days. Label the vial with the reconstitution date. Use sterile handling, mix gently rather than shaking, avoid repeated freeze-thaw cycles, and do not use material showing persistent particles, unexpected cloudiness, or discoloration.
Twenty milligrams of lyophilized material can form a thin cake, film, or light residue on the vial wall or base. Let the vial stand upright and inspect it under good lighting. Appearance alone does not confirm the labeled mass; consult the lot-specific COA when quantitative confirmation is required.
Keep the vial upright and allow it to reach room temperature before opening. Add the selected laboratory solvent slowly down the inside wall so it contacts the material gradually.
Gently swirl or roll the vial. Do not shake vigorously. If bubbles form, allow the vial to rest refrigerated until the solution settles.
Confirm the solvent, volume, and preparation method, then allow the vial to rest at 2-8°C and inspect it again. If particles, cloudiness, or discoloration persist, quarantine the vial and contact support with photographs, the lot number, solvent, volume, and preparation date.
Use sterile technique, disinfect the stopper before each access, avoid touching sterile surfaces, and return the vial promptly to refrigerated storage. Discard the solution after 30 days or sooner if contamination is suspected.
This product contains Cartalax 20 mg per vial and 10 vials per kit. Check the product name, specification, SKU, and lot-specific COA. A multi-component blend is a different product and should not be treated as analytically interchangeable.
Contact our online support for real-time communication about products, orders, shipping, payment, or bulk supply.
